Steven Andrew Curti, MD
Otolaryngology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Curti’s office at (650) 327-3232 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence A167583 · Current
Licensed to practise in California · since 2020 · expires 2028-01-31 · University of Missouri-Kansas City School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$27,282
Medicare paid this office $27,282 for 32 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (45+ min) | 16 | $2,535 | $158 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
Who their Medicare patients are
32 Original Medicare patients in 2024. Average age 77 · Women 66% · Health risk score 0.97. At or below the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 69%.
The office billed $144,200, Medicare allowed $34,242 and paid $27,282; for 66 services of 23 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 32 | 66 | 77 | 0.97 | $144,200 | $27,282 |
| 2023 | 14 | 24 | 77 | 1.00 | $39,428 | $9,524 |
| 2022 | 464 | 953 | 76 | 1.35 | $194,002 | $64,796 |
| 2021 | 324 | 664 | 75 | 1.20 | $121,802 | $52,725 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2022: 8 services
| Short return visit (20+ min) | 249 | $17,707 | $55 |
| New patient visit (30+ min) | 175 | $11,345 | $65 |
| New patient visit (45+ min) | 65 | $6,201 | $95 |
| Removal of impacted ear wax | 131 | $4,038 | $27 |
| Return visit (30+ min) | 43 | $3,906 | $81 |
| Diagnostic exam of voice box using a flexible endoscope | 41 | $3,607 | $72 |
| Diagnostic exam of nasal passages using an endoscope | 22 | $3,455 | $133 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $694 | $53 |
2021: 7 services
| Short return visit (20+ min) | 160 | $13,103 | $67 |
| New patient visit (30+ min) | 106 | $8,297 | $78 |
| New patient visit (45+ min) | 62 | $7,550 | $122 |
| Diagnostic exam of voice box using a flexible endoscope | 52 | $4,925 | $88 |
| Return visit (30+ min) | 45 | $4,713 | $96 |
| Diagnostic exam of nasal passages using an endoscope | 21 | $3,506 | $140 |
| Removal of impacted ear wax | 85 | $3,036 | $33 |
Medicaid work
$8,559 in 2022
Medicaid paid $8,559 for 221 billed services this clinician did in 2022, up to 22 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (30+ min) | 107 | $4,722 |
| Short return visit (20+ min) | 101 | $2,830 |
| New patient visit (45+ min) | 13 | $1,007 |
| 2022 | 221 | 3 | 22 | $8,559 |
| 2021 | 15 | 1 | 12 | $353 |
See the largest Medicaid services in earlier years
2021
| Short return visit (20+ min) | 15 | $353 |
Drugs they prescribed that Part D paid
$761
Pharmacies billed $761 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 20% of their Part D prescriptions (13 of 66) in 2024. Above the middle of the specialty; the typical otolaryngology clinician is at 4%.
65 generic and fewer than 11 brand-name prescriptions · $761 in drug cost · 22 antibiotic prescriptions to 18 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cephalexin | 11 | $59 | $5 |
Year by year
| 2024 | 66 | 21 | 20% (13) | None | $761 |
| 2023 | 42 | 16 | None | 0% | $715 |
| 2022 | 350 | 158 | 4% (15) | None | $7,030 |
| 2021 | 128 | 73 | None | None | $2,331 |
| 2020 | 89 | 33 | 16% (14) | None | $1,436 |
| 2019 | 85 | 45 | None | None | $4,430 |
| 2018 | 132 | 50 | 12% (16) | 12% | $5,117 |
| 2017 | 166 | 81 | 19% (32) | None | $2,330 |
| 2016 | 64 | 32 | 30% (19) | 19% | $2,908 |
| 2015 | 26 | 14 | 42% (11) | None | $458 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 10 drugs
| Ipratropium | 39 | $1,355 | $35 |
| Fluticasone Propionate | 88 | $1,326 | $15 |
| Pilocarpine | 15 | $1,084 | $72 |
| Ofloxacin | 15 | $670 | $45 |
| Doxycycline Hyclate | 20 | $339 | $17 |
| Omeprazole | 11 | $221 | $20 |
| Amoxicillin-Clavulanate Potass | 16 | $198 | $12 |
| Mupirocin | 20 | $180 | $9 |
| Pantoprazole | 20 | $134 | $7 |
| Amoxicillin | 13 | $31 | $2 |
2021: 1 drug
| Fluticasone Propionate | 22 | $278 | $13 |
2020: 4 drugs
| Pantoprazole | 12 | $78 | $7 |
| Cephalexin | 13 | $69 | $5 |
| Hydrocodone-Acetaminophen | 14 | $64 | $5 |
| Famotidine | 15 | $57 | $4 |
2018: 4 drugs
| Fluticasone Propionate | 13 | $202 | $16 |
| Ranitidine | 18 | $138 | $8 |
| Hydrocodone-Acetaminophen | 16 | $107 | $7 |
| Ondansetron | 15 | $93 | $6 |
2017: 4 drugs
| Hydrocodone-Acetaminophen | 31 | $444 | $14 |
| Fluticasone Propionate | 23 | $279 | $12 |
| Omeprazole | 25 | $207 | $8 |
| Ondansetron | 20 | $175 | $9 |
2016: 1 drug
| Hydrocodone-Acetaminophen | 12 | $84 | $7 |
Money from drug and device companies
$147 in 2025
| 2025 | 1 | 2 | None | $147 |
| 2024 | 2 | 4 | $73 | $357 |
| 2023 | 2 | 12 | $16 | $468 |
| 2022 | 2 | 3 | $70 | $194 |
| 2021 | 1 | 1 | None | $13 |
| 2020 | 2 | 6 | None | $111 |
| 2019 | 1 | 1 | None | $146 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Botox | $147 | 2 payments
|
See all 2 published payments
| Abbvie | Meals · 2025-04-25 | Botox | $128 |
| Abbvie | Meals · 2025-02-11 | Botox | $19 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $357
| Galderma Laboratories L.P. | None | $284 | 2 payments
|
| Abbvie | None | $73 | 2 payments
|
2023: $468
| AbbVie | None | $329 | 11 payments
|
| Galderma Laboratories L.P. | None | $139 | 1 payment
|
2022: $194
| Regeneron Healthcare Solutions | Dupixent | $124 | 1 payment
|
| Medtronic | Merocel | $70 | 2 payments
|
2021: $13
| Boston Scientific | Lux-Dx | $13 | 1 payment
|
2020: $111
| Galderma Laboratories L.P. | None | $78 | 4 payments
|
| Boston Scientific | Lux-Dx | $33 | 2 payments
|
2019: $146
| Galderma Laboratories L.P. | None | $146 | 1 payment
|
Professional record
- NPI
- 1023496650
- Licence
- CA A167583California A167583: Current · expires 2028-01-31
- Trained
- University of Missouri, Kansas City, School of Medicine, 2015
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207YS0123X (207YS0123X)
- Mailing address
- 326 Village Ln, Los Gatos, CA, 95030
- NPI first listed
- 2015-05-15
- NPI last updated
- 2022-09-21
- NPI record certified
- 2022-09-21
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 810 Altos Oaks Dr, Los Altos, CA, 94024